196 related articles for article (PubMed ID: 29683037)
1. Pharmacological Differentiation of Thrombomodulin Alfa and Activated Protein C on Coagulation and Fibrinolysis In Vitro.
Tanaka K; Tawara S; Tsuruta K; Hoppensteadt D; Fareed J
Clin Appl Thromb Hemost; 2018 Sep; 24(6):859-866. PubMed ID: 29683037
[TBL] [Abstract][Full Text] [Related]
2. Regulation of fibrinolysis in plasma by TAFI and protein C is dependent on the concentration of thrombomodulin.
Mosnier LO; Meijers JC; Bouma BN
Thromb Haemost; 2001 Jan; 85(1):5-11. PubMed ID: 11204587
[TBL] [Abstract][Full Text] [Related]
3. Characteristic effects of activated human protein C on tissue thromboplastin-induced disseminated intravascular coagulation in rabbits.
Katsuura Y; Aoki K; Tanabe H; Kiyoki M; Funatsu A
Thromb Res; 1994 Nov; 76(4):353-62. PubMed ID: 7871494
[TBL] [Abstract][Full Text] [Related]
4. Anti-inflammatory and anti-fibrinolytic effects of thrombomodulin alfa through carboxypeptidase B2 in the presence of thrombin.
Tawara S; Sakai T; Matsuzaki O
Thromb Res; 2016 Nov; 147():72-79. PubMed ID: 27693845
[TBL] [Abstract][Full Text] [Related]
5. Thrombomodulin alfa attenuates the procoagulant effect and cytotoxicity of extracellular histones through the promotion of protein C activation.
Osada K; Minami T; Arioka T; Sakai T; Tawara S; Kawasaki K; Fareed J; Matsuzaki O
Thromb Res; 2017 Dec; 160():51-57. PubMed ID: 29101790
[TBL] [Abstract][Full Text] [Related]
6. The profibrinolytic effect of plasma thrombomodulin in factor XI deficiency and its implications in hemostasis.
Dai L; Mitchell M; Savidge G; Alhaq A
J Thromb Haemost; 2004 Dec; 2(12):2200-4. PubMed ID: 15613027
[TBL] [Abstract][Full Text] [Related]
7. The impact of the endothelial protein C receptor on thrombin generation and clot lysis.
Pepler L; Wu C; Dwivedi DJ; Wu C; Kim PY; Liaw PC
Thromb Res; 2017 Apr; 152():30-37. PubMed ID: 28219843
[TBL] [Abstract][Full Text] [Related]
8. Activated protein C accelerates clot lysis by virtue of its anticoagulant activity.
de Fouw NJ; van Tilburg NH; Haverkate F; Bertina RM
Blood Coagul Fibrinolysis; 1993 Apr; 4(2):201-10. PubMed ID: 8388739
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin: a linker of coagulation and fibrinolysis and predictor of risk of arterial thrombosis.
Wu KK; Matijevic-Aleksic N
Ann Med; 2000 Dec; 32 Suppl 1():73-7. PubMed ID: 11209986
[TBL] [Abstract][Full Text] [Related]
10. Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy.
Burley K; Whyte CS; Westbury SK; Walker M; Stirrups KE; Turro E; ; Chapman OG; Reilly-Stitt C; Mutch NJ; Mumford AD
Blood; 2016 Oct; 128(14):1879-1883. PubMed ID: 27436851
[TBL] [Abstract][Full Text] [Related]
11. An antifibrinolytic effect associated with an anti-factor V antibody in a patient with severe thrombophilia.
Colucci M; Simioni P; Piro D; Prandoni P; Pagnan A; Semeraro N
Haematologica; 2003 Dec; 88(12):1383-9. PubMed ID: 14687992
[TBL] [Abstract][Full Text] [Related]
12. Protein C inhibitor regulates the thrombin-thrombomodulin complex in the up- and down regulation of TAFI activation.
Mosnier LO; Elisen MG; Bouma BN; Meijers JC
Thromb Haemost; 2001 Oct; 86(4):1057-64. PubMed ID: 11686324
[TBL] [Abstract][Full Text] [Related]
13. Protein C inhibitor acts as a procoagulant by inhibiting the thrombomodulin-induced activation of protein C in human plasma.
Elisen MG; von dem Borne PA; Bouma BN; Meijers JC
Blood; 1998 Mar; 91(5):1542-7. PubMed ID: 9473218
[TBL] [Abstract][Full Text] [Related]
14. Effect of protein C and activated protein C on coagulation and fibrinolysis in normal human subjects.
Okajima K; Koga S; Kaji M; Inoue M; Nakagaki T; Funatsu A; Okabe H; Takatsuki K; Aoki N
Thromb Haemost; 1990 Feb; 63(1):48-53. PubMed ID: 2140205
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin-resistant prothrombin Yukuhashi mutation also causes thrombomodulin resistance in fibrinogen clotting but not in protein C activation.
Takagi Y; Kato I; Ando Y; Nakamura Y; Murata M; Takagi A; Murate T; Kojima T
Thromb Res; 2014 Oct; 134(4):914-7. PubMed ID: 25149909
[TBL] [Abstract][Full Text] [Related]
16. Protein C and fibrinolysis: a link between coagulation and fibrinolysis.
de Fouw NJ; Haverkate F; Bertina RM
Adv Exp Med Biol; 1990; 281():235-43. PubMed ID: 2102614
[TBL] [Abstract][Full Text] [Related]
17. The paradoxical antifibrinolytic effect of dabigatran and argatroban in the presence of soluble thrombomodulin is unrelated to protein C-dependent increase of thrombin generation.
Incampo F; Carrieri C; Semeraro N; Colucci M
Thromb Res; 2014 Nov; 134(5):1110-6. PubMed ID: 25193406
[TBL] [Abstract][Full Text] [Related]
18. Relationship between soluble thrombomodulin in plasma and coagulation or fibrinolysis in type 2 diabetes.
Aso Y; Fujiwara Y; Tayama K; Takebayashi K; Inukai T; Takemura Y
Clin Chim Acta; 2000 Nov; 301(1-2):135-45. PubMed ID: 11020468
[TBL] [Abstract][Full Text] [Related]
19. Thrombomodulin accelerates activated protein C production and inhibits thrombin generation in the plasma of disseminated intravascular coagulation patients.
Wada H; Sakakura M; Kushiya F; Nisikawa M; Onishi K; Nakatani K; Shiku H; Nobori T
Blood Coagul Fibrinolysis; 2005 Jan; 16(1):17-24. PubMed ID: 15650541
[TBL] [Abstract][Full Text] [Related]
20. Hyperprothrombinaemia-induced APC resistance: differential influence on fibrin formation and fibrinolysis.
Binetti BM; Rotunno C; Tripodi A; Asti D; Semeraro F; Semeraro N; Colucci M
Thromb Haemost; 2006 Apr; 95(4):606-11. PubMed ID: 16601829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
